Clinical Study of Intravitreal Injection of Anti-VEGF Drugs Combined with Triamcinolone Acetonide in the Treatment of Coats Disease
- PMID: 35756410
- PMCID: PMC9232298
- DOI: 10.1155/2022/9911549
Clinical Study of Intravitreal Injection of Anti-VEGF Drugs Combined with Triamcinolone Acetonide in the Treatment of Coats Disease
Retraction in
-
Retracted: Clinical Study of Intravitreal Injection of Anti-VEGF Drugs Combined with Triamcinolone Acetonide in the Treatment of Coats Disease.Comput Math Methods Med. 2023 Jul 19;2023:9891537. doi: 10.1155/2023/9891537. eCollection 2023. Comput Math Methods Med. 2023. PMID: 37503376 Free PMC article.
Abstract
Objective: To investigate the clinical study of intravitreal injection of anti-VEGF drugs combined with intravitreal injection of tretinoin for the treatment of Coats disease.
Methods: The medical records of 90 patients (120 eyes) with Coats disease admitted to our hospital from April 2010 to June 2021 were selected as retrospective study subjects and divided into control and treatment groups according to the numerical table method. There were 45 cases and 60 eyes in each group. Among them, intravitreal tretinoin drug was injected into the control group, and anti-VEGF drug was injected into the vitreous sclera of the treatment group on the basis of the control group.
Results: Before treatment, the differences in visual acuity changes between the two groups were not statistically significant (P > 0.05). After treatment, the light perception, manipulation, and indexes of both groups were significantly improved, and the treatment group was significantly better than the control group. This difference was statistically significant (P < 0.05) for statistical study comparison. The effective rate of 95.56% in the treatment group was significantly higher than that of 86.67% in the control group, and the complication rate was significantly lower than that of the control group, with statistically significant differences (P < 0.05).
Conclusion: Intravitreal injection of anti-VEGF drugs combined with tretinoin injection can significantly improve the clinical efficacy of patients with Coats disease and improve visual acuity and central retinal thickness, which has certain reference value for the clinical treatment of Coats disease.
Copyright © 2022 ShaoFeng Wu et al.
Conflict of interest statement
The authors declared that they have no conflicts of interest regarding this work.
Similar articles
-
Combination treatment of pediatric coats' disease: a bicenter study in Taiwan.J Pediatr Ophthalmol Strabismus. 2013 Nov-Dec;50(6):356-62. doi: 10.3928/01913913-20131125-02. J Pediatr Ophthalmol Strabismus. 2013. PMID: 24669373
-
Prospective study of intravitreal triamcinolone acetonide versus bevacizumab for macular edema secondary to central retinal vein occlusion.Retina. 2011 May;31(5):838-45. doi: 10.1097/IAE.0b013e3181f4420d. Retina. 2011. PMID: 21293319 Clinical Trial.
-
Comparison of intravitreal injection of bevacizumab and triamcinolone acetonide in the treatment of uveitic macular edema.Iran J Immunol. 2012 Jun;9(2):136-44. Iran J Immunol. 2012. PMID: 22735801 Clinical Trial.
-
[Intravitreal triamcinolone acetonide for the treatment of intraocular edematous and neovascular diseases].Ophthalmologe. 2004 Feb;101(2):113-20. doi: 10.1007/s00347-003-0982-0. Ophthalmologe. 2004. PMID: 14991306 Review. German.
-
Clinical evidence of intravitreal triamcinolone acetonide in the management of age-related macular degeneration.Curr Drug Targets. 2011 Feb;12(2):149-72. doi: 10.2174/138945011794182746. Curr Drug Targets. 2011. PMID: 20887246 Review.
Cited by
-
Retracted: Clinical Study of Intravitreal Injection of Anti-VEGF Drugs Combined with Triamcinolone Acetonide in the Treatment of Coats Disease.Comput Math Methods Med. 2023 Jul 19;2023:9891537. doi: 10.1155/2023/9891537. eCollection 2023. Comput Math Methods Med. 2023. PMID: 37503376 Free PMC article.
-
Design and Optimization of Solid Lipid Nanoparticles Loaded with Triamcinolone Acetonide.Molecules. 2023 Jul 29;28(15):5747. doi: 10.3390/molecules28155747. Molecules. 2023. PMID: 37570717 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous